Literature DB >> 21325887

Ionizing radiation-induced TAp63α phosphorylation at C-terminal S/TQ motifs requires the N-terminal transactivation (TA) domain.

Dal-Ah Kim1, Byong-Linne Lee, Eun-Kyung Suh.   

Abstract

TAp63α, a homolog of p53 and one of six alternatively spliced p63 isoforms, is a critical mediator of the ionizing radiation (IR)-induced DNA damage response in female germ cells and also tumor suppression in somatic cells. The ΔNp63α isoform, lacking the N-terminal transactivation (TA) domain, is associated with oncogenic potential. The mechanism of p63 functional regulation is not well understood. TAp63α is phosphorylated by ionizing radiation (IR)-induced DNA damage and gene transactivation is likely to be involved. Based on information gleaned from studies on p53, we explored the possibility that TAp63α S/TQ sites may be phosphorylated by IR-induced DNA damage. Our findings show a wortmanin-sensitive kinase phosphorylates TAp63α at C-terminal Ser-Gln and Thr-Gln (S/TQ) sites but not N-terminal S/TQ sites. ΔNp63α, lacking the TA domain, and TAp63γ, lacking C-terminal domains, including S/TQ sites, fail to undergo IR-induced phosphorylation. We propose a model for TA domain-dependent C-terminal phosphorylation drawing from previously described self-inactivating intramolecular interaction between N-terminal TA domain and C-terminal Transactivation Inhibitory Domain (TID) of TAp63α. A specific topology adopted only by TAp63α, but not possible for ΔNp63α or TAp63γ, may lead to TAp63α-specific kinase recruitment, phosphorylation and self-inactivation release. TID-lacking TAp63γ, like p53, is constitutively active and thus may forgo phosphorylation-dependent activation. Thus, p53 is regulated by protein stabilization and TAp63α by protein activation but both appear to involve S/TQ phosphorylation. The difference in phosphorylation potential of TAp63α and ΔNp63α may in part help explain why the two similar isoforms have diametrically opposite tumor suppression and oncogene functions, respectively.
© 2011 Landes Bioscience

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21325887     DOI: 10.4161/cc.10.5.15008

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  6 in total

1.  Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.

Authors:  Eleni Vakonaki; Nikolaos Soulitzis; Stavros Sifakis; Danae Papadogianni; Dimitrios Koutroulakis; Demetrios A Spandidos
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-24       Impact factor: 4.553

Review 2.  The Role of Mutant p63 in Female Fertility.

Authors:  Yi Luan; Pauline Xu; Seok-Yeong Yu; So-Youn Kim
Journal:  Int J Mol Sci       Date:  2021-08-20       Impact factor: 5.923

3.  Defying DNA double-strand break-induced death during prophase I meiosis by temporal TAp63α phosphorylation regulation in developing mouse oocytes.

Authors:  Dal-Ah Kim; Eun-Kyung Suh
Journal:  Mol Cell Biol       Date:  2014-02-10       Impact factor: 4.272

4.  Tissue-specific expression of p73 C-terminal isoforms in mice.

Authors:  Francesca Grespi; Ivano Amelio; Paola Tucci; Margherita Annicchiarico-Petruzzelli; Gerry Melino
Journal:  Cell Cycle       Date:  2012-11-16       Impact factor: 4.534

Review 5.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Richard A Franklin; Giuseppe Montalto; Melchiorre Cervello; Massimo Libra; Saverio Candido; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Ferdinando Nicoletti; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Francesca Chiarini; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-10

6.  Quality control in oocytes by p63 is based on a spring-loaded activation mechanism on the molecular and cellular level.

Authors:  Daniel Coutandin; Christian Osterburg; Ratnesh Kumar Srivastav; Manuela Sumyk; Sebastian Kehrloesser; Jakob Gebel; Marcel Tuppi; Jens Hannewald; Birgit Schäfer; Eidarus Salah; Sebastian Mathea; Uta Müller-Kuller; James Doutch; Manuel Grez; Stefan Knapp; Volker Dötsch
Journal:  Elife       Date:  2016-03-14       Impact factor: 8.140

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.